Biologic role of the plasminogen-plasmin system: thrombolysis, bleeding, and beyond.

نویسندگان

  • Hau C Kwaan
  • Andrew P Mazar
چکیده

a role for the canonical plasminogen receptor, annexin A2, in diseases,s followed by a molecular view of the uPA receptor (uPAR) by Ferraris and Sidenius.6 Another member of the P-P system that has a versatile role in biology and the pathogenesis of many diseases is PAI-1 and its implication on various processes is expanding almost on a daily basis. A series of reviews on this emerging important therapeutic target follow An update o[our understanding of this molecule is given by Declerck and Gils.7 This is followed by a description of the more recently discovered inhibitor of plasmin and plasminogen activator, the thrombin activatable fibrinolytic inhibitor, which is discussed by Vercauteren et al.8 As PAI-1 is now recognized to be of the key factors in pulmonary flbrosis, and so an account o[this is provided by Tucker and ldell.e Much recent work has been devoted to determine the importance of the P-P system in cancer. uPA, uPAR, and PAIt have all been implicated in tumor progression, and expression of these various components is associated with poor prognosis in various cancer types. In particular, the uPAR is a key member in the complex interactions of this system that drive tumor progression. This is reviewed by I(waan et a1.10 The role of the P-P system is also emerging in various other

منابع مشابه

پتانسیل آنتی‌پلاسمینوژن منوکلونال آنتی‌بادی در دستکاری دو سیستم فیبرینولیز و آنژیوژنز

Background: Plasminogen has a central role in fibrinolyrtic system can activate through various activators (PAs) to its active form plasmin and perfoem its vital function that is fibrin clot lysis. Furthermore the fibrinolyrtic system plays a major role in angiogenesis. The fibrinolyrtic system activation control cell migration and invasion. In addition to this, plasmin regulates tumor growth. ...

متن کامل

A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.

Tissue-type plasminogen activator (t-PA) is a promising thrombolytic agent because it can produce thrombolysis without inducing a plasma proteolytic state. It is uncertain if this potentially important feature renders t-PA less hemorrhagic than other plasminogen activators. We have compared the hemorrhagic and thrombolytic effects of t-PA and streptokinase in rabbits. Streptokinase, 4000 U/kg/h...

متن کامل

Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage.

All thrombolytic agents in current clinical usage are plasminogen activators. Although effective, plasminogen activators uniformly increase the risk of bleeding complications, especially intracranial hemorrhage, and no laboratory test is applicable to avoid such bleeding. We report results of a randomized, blinded, dose-ranging comparison of tissue-type plasminogen activator (TPA) with a direct...

متن کامل

Thrombolysis with plasmin: implications for stroke treatment.

Plasmin is a direct-acting thrombolytic agent with a striking hemostatic safety advantage over plasminogen activators in animal models of thrombolysis and bleeding. In contradistinction to plasminogen activators, which risk bleeding at any effective thrombolytic dose, plasmin is tolerated without bleeding at several-fold higher amounts than those needed for thrombolysis. Plasmin has been safe i...

متن کامل

Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases.

Alterations in thrombosis and fibrinolysis comprise important parts of stroke pathophysiology. A key step in the fibrinolytic process includes the tissue-type plasminogen activator (tPA)-mediated conversion of the proenzyme plasminogen into the active protease plasmin, which in turn degrades the fibrin structure of intravascular thrombi. There are a number of review articles well summarizing mo...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

متن کامل
عنوان ژورنال:
  • Seminars in thrombosis and hemostasis

دوره 39 4  شماره 

صفحات  -

تاریخ انتشار 2013